Ellsworth Advisors »

Corcept Therapeutics Incorporated shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $769k 10k 76.81

More positions owned by Ellsworth Advisors

Spdr Gold Tr Gold Shs (GLD)
Celestica (CLS)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded First Tr Enh New (FTSM)
Apple (AAPL)
Harbor Etf Trust Harbor Commodity (HGER)
Advanced Micro Devices (AMD)
Johnson & Johnson (JNJ)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Amgen (AMGN)
Enterprise Products Partners (EPD)
Altria (MO)
Cisco Systems (CSCO)

View all positions for Ellsworth Advisors

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated